12:00 AM
 | 
Oct 20, 2003
 |  BioCentury  |  Analyst Picks & Changes

Analyst picks & changes

Millennium Pharmaceuticals Inc.

(MLNM), Cambridge, Mass.

Business: Cancer, Cardiovascular, Inflammation

Deutsche Bank analyst Dennis Harp raised his price target to $15...

Read the full 104 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >